IGM Biosciences

$59.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.72 (-4.36%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell IGMS and other stocks, options, and ETFs commission-free!

About IGMS

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies.

CEO
Fred M. Schwarzer
Employees
107
Headquarters
Mountain View, California
Founded
2010
Market Cap
1.91B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
194.86K
High Today
$62.30
Low Today
$58.81
Open Price
$62.30
Volume
158.95K
52 Week High
$133.00
52 Week Low
$41.41

IGMS Earnings

-$2.41
-$1.61
-$0.80
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

VALU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure